Information Provided By:
Fly News Breaks for November 3, 2016
QGEN
Nov 3, 2016 | 06:42 EDT
BofA/Merrill analyst Derik de Bruin upgraded QIAGEN to Neutral and raised its price target to $26 from $25 following the Q3 report and solid FY17 guidance. The company sees accelerating FY17 growth and the first double-digit increase since 2012 and said its Unperform thesis is played out.
News For QGEN From the Last 2 Days
There are no results for your query QGEN
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.